Senate Finance Chair continues his investigation into pharma taxes with requests for Amgen

Amgen is the latest pharma company to appear on the radar of Senate Finance Committee Chair Ron Wyden (D-OR), who is investigating the way pharma companies are using subsidiaries in low- or zero-tax countries to lower their tax bills.

Bob Bradway

Like its peers…